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Abstract
Virus-induced apoptosis and viral mechanisms that regulate this cell death program are key issues in understanding virus-
host interactions and viral pathogenesis. Like many other human and animal viruses, coronavirus infection of mammalian
cells induces apoptosis. In this study, the global gene expression profiles are first determined in IBV-infected Vero cells at
24 hours post-infection by Affymetrix array, using avian coronavirus infectious bronchitis virus (IBV) as a model system. It
reveals an up-regulation at the transcriptional level of both pro-apoptotic Bak and pro-survival myeloid cell leukemia-1 (Mcl-
1). These results were further confirmed both in vivo and in vitro, in IBV-infected embryonated chicken eggs, chicken
fibroblast cells and mammalian cells at transcriptional and translational levels, respectively. Interestingly, the onset of
apoptosis occurred earlier in IBV-infected mammalian cells silenced with short interfering RNA targeting Mcl-1 (siMcl-1), and
was delayed in cells silenced with siBak. IBV progeny production and release were increased in infected Mcl-1 knockdown
cells compared to similarly infected control cells, while the contrary was observed in infected Bak knockdown cells.
Furthermore, IBV infection-induced up-regulation of GADD153 regulated the expression of Mcl-1. Inhibition of the mitogen-
activated protein/extracellular signal-regulated kinase (MEK/ERK) and phosphoinositide 3-kinase (PI3K/Akt) signaling
pathways by chemical inhibitors and knockdown of GADD153 by siRNA demonstrated the involvement of ER-stress
response in regulation of IBV-induced Mcl-1 expression. These results illustrate the sophisticated regulatory strategies
evolved by a coronavirus to modulate both virus-induced apoptosis and viral replication during its replication cycle.
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Introduction
Virus-induced eukaryotic cell death typically follows one of the
two paths: apoptosis or necrosis. The execution of either one or the
other in virus-infected cells, thus, reflects the pathogenicity of
viruses [1]. Apoptosis is a highly conserved and strictly controlled
physiological process by which unwanted cells are selectively
eliminated. This mechanism also plays a critical role in normal
development [2], stress response and adaptation [3]. Apoptotic
cells undergo many distinct morphological and biochemical
changes. Nuclear and/or cytoplasmic condensation, as well as
membrane protrusion, is initiated. Nuclear fragmentation then
follows suit, resulting in the subsequent encapsulation of these
fragments into apoptotic bodies that are rapidly and unobtrusively
phagocytosed without eliciting an inflammatory response [4].
Necrosis, in contrast, is not self initiated but instead arises from an
insult or injury to the cell, such as cytotoxicity or mechanical
damage [5]. Characteristics of necrosis include significantly less
DNA degradation as compared to apoptosis and a major loss of
membrane integrity, resulting in leakage of cell contents and
eliciting an inflammatory response from the surrounding cells [6].
Apoptotic mitochondrial events are regulated primarily through
the activation of pro-survival and pro-apoptotic proteins [7]. The
Bcl-2 (B cell lymphoma-2) family of proteins constitutes a critical
control point in the regulation of apoptosis. They form three major
protein subgroups: the BH3 (Bcl-2 homology)-only proteins (e.g.,
Bid, Bad), Bax-like proteins (e.g., Bax, Bak) and the Bcl-2-like
factors (e.g., Mcl-1, Bcl- XL) [8]. BH3-only and Bax-like proteins
are essential initiators of apoptosis while the Bcl-2-like proteins are
pro-survival factors that safeguard the cells against apoptosis. An
increase in the expression of pro-apoptotic proteins of the Bcl-2
family such as Bax and Bak, which can form pores in the outer
mitochondrial membrane, induces the efflux of cytochrome-c from
the mitochondria into the cytosol [9]. Cytochrome-c then
complexes with Apaf-1 and pro-caspase 9 to activate caspase 9,
which leads to the subsequent activation of caspase-3 and -7 [10].
Bak and Bax can also be recruited to the endoplasmic reticulum
(ER) and initiate apoptosis in response to stress [11]. On the other
hand, Bak heterodimerization with Bcl-2-like anti-apoptotic
factors, such as Mcl-1 and Bcl-XL, suppresses Bak homo-
oligomerization and pore formation in unstressed, healthy cells
[12,13].
Apoptosis is also an important antiviral defense mechanism of
the host cell that leads to the abortion of virus infection and
consequently limits viral productivity and infectivity [14].
However, certain viruses have evolved strategies to both
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production of virus progeny and promote its spread to neigh-
bouring cells. An increasing number of viruses from different
families, including two coronaviruses, has been found to induce
apoptosis during their infection cycles, which may possibly
contribute to the cytotoxicity associated with virus infections
[15]. Specifically, the avian coronavirus infectious bronchitis virus
(IBV) has been shown to induce caspase-dependent apoptosis in
infected African green monkey Vero cells [16]. As important
pathogens of both human and animals, coronaviruses are
generally associated with respiratory diseases, including the severe
acute respiratory syndrome coronavirus (SARS-CoV) [17]. IBV is
the etiological agent of infectious bronchitis, an acute disease that
renders the respiratory and urogenital tracts of chicken irreparable
[18,19]. While it extensively destroys the mucosae of the
respiratory tract, the impact of IBV infection is greatly magnified
as a consequence of its enhancement of diseases associated with
co-infections by bacteria and mycoplasmas [20,21]. Although IBV
is an avian virus, it is reported to adapt well to primate cells and
has also been shown to infect human and animal cells [22,23].
DNA damage response is one strategy IBV employs to trigger
DNA replication stress in IBV-infected cells, subsequently leading
to cell cycle arrest [24]. Recent reports have also shown the up-
regulation of dual-specificity phosphatase 1 (DUSP1), which
negatively regulates p38 mitogen-activated protein kinase (MAPK)
pathway, culminating in the suppression of excessive induction of
the pro-inflammatory cytokines such as interleukin (IL)-6 and IL-8
[25]. However, the mechanisms by which IBV induces and
regulates apoptosis remain under investigation.
In this paper, the role of apoptosis in the coronavirus life cycle is
studied. Using IBV as a model system, we investigated the
underlying effects of pro- and anti-apoptotic protein expression on
coronavirus infectivity and virus-induced apoptosis through
systematic characterization of Bak and Mcl-1 expression at both
transcriptional and translational levels in IBV-infected cells. We
showed that IBV infection up-regulated Bak and Mcl-1 at both
transcriptional and translational levels. We also checked the
expression levels of Bak and Mcl-1 in IBV-infected chicken
embryos and chicken fibroblast cells and confirmed a similar up-
regulation trend at the transcriptional level. Targeted Bak and
Mcl-1 down-regulation by siRNA revealed that IBV progeny
production was enhanced in cells depleted of the pro-survival Mcl-
1 protein and decreased in that of the pro-apoptotic Bak.
Furthermore, IBV-induced apoptosis appeared earlier in Mcl-1
knockdown cells, and later in Bak knockdown cells, indicating the
possibility that Mcl-1 and Bak may play diverging roles in the
regulation of coronavirus-induced apoptosis. Lastly, we studied the
upstream signaling pathways leading to infection-mediated Mcl-1
induction and identified components of the MAP/ERK, PI3K/
Akt and GADD153 in the endoplasmic reticulum (ER) stress
pathways as potential modulators.
Materials and Methods
Cells, viruses and antibodies
Vero, Huh7 and chicken fibroblast DF1 cells were maintained
in high glucose (4 500 mg/L) Dulbecco’s modified Eagle’s
medium (DMEM) supplied with 10% fetal bovine serum (FBS)
and 1% Penicillin-Streptomycin (PS) antibodies (Gibco-BRL,
California, USA). H1299 cells were maintained in RPMI 1640
containing 10 mM HEPES with 10% FBS and 1% PS. All cells
were grown in a 37uC incubator supplied with 5% CO2.
Confluent monolayers were subcultured using trypsin-EDTA in
Ca
2+- and Mg
2+-free phosphate-buffered saline (PBS) containing
0.02% EDTA. Cells were changed to FBS free medium prior to
virus infection.
Vero cell-adapted Beaudette strain of IBV stock [22,26,27] was
prepared by infection of Vero cells with 0.1 plaque forming unit
(PFU) of IBV per cell, followed by incubation at 37uCi na
humidified 5% CO2 atmosphere. Virus stocks were made through
three repeated freeze-thaw cycles and kept at 280uC in 0.5–1 ml
aliquots until use. Mock virus stocks were similarly made using
three repeated freeze-thaw cycles of Vero cells. All recombinant
and wild-type IBVs were propagated in Vero cells in FBS-free
DMEM.
Anti-IBV-S and anti-IBV-N polyclonal antibodies were raised
in rabbits as described previously [28]; anti-Bak monoclonal
antibody was purchased from Calbiochem (EMD Biosciences,
California, USA); anti-actin polyclonal, anti-Bax and anti-Mcl-1
monoclonal antibodies from Santa Cruz (Santa Cruz Biotechnol-
ogy, California, USA); anti-tubulin monoclonal and anti-myc
polyclonal antibody from Sigma; anti-PARP monoclonal anti-
body, anti-CHOP/GADD153 monoclonal antibody and anti-Bcl-
2 monoclonal antibody from Cell Signaling Technology (Cell
Signaling Technology, Inc., Massachusetts, USA). Polyclonal goat
anti-mouse IgG, polyclonal rabbit anti-goat IgG and polyclonal
mouse anti-rabbit IgG secondary antibodies, all conjugated with
horseradish peroxidase (HRP), were purchased from Dako (Dako,
Glostrup, Denmark).
Infection of chicken embryos
Ten-day-old embryonated, pathogen-free chicken eggs (Lim
Chu Kang Veterinary Station, Singapore) were inoculated with
IBV as described previously [29]. The allantoic fluid and different
organs were harvested after the embryos were chilled at 4uC
overnight. Total RNA was extracted from the homogenized tissues
and used for RT-PCR with oligo(dT) 18.
UV inactivation of IBV
IBV was exposed to 120 000 mJ/cm2 of 254-nm shortwave UV
radiation for 10 minutes within a CL-1000 cross-linker (UVP). To
confirm that IBV had been inactivated, Western blotting was used
to determine the presence or absence of viral proteins in cells
infected with UV-inactivated virus.
Virus titration
60% confluent monolayers of H1299 cells grown on 6-well
plates were transfected with siRNAs targeting Mcl-1 (siMcl-1), Bak
(siBak), and EGFP (siEGFP) using DharmaFECT transfection
reagent according the manufacturer’s instructions (Dharmacon,
Thermo Fisher Scientific Inc., USA). At 72 hours post-transfec-
tion, cells were infected with IBV at a multiplicity of infection
(M.O.I.) of 0.1, and harvested at various time points within a 0–
24 hour interval post-infection for virus titration through plaque
assay.
Confluent monolayers of Vero cells on six-well plates were
infected with 100 ml of 10-fold serially diluted virus stock. After
1 hour of incubation at 37uC, cells were washed twice with PBS
and cultured in 3 ml of DMEM containing 0.5% carboxymethyl
cellulose for 3 days. The cells were fixed and stained with 0.1%
toluidine blue. The number of plaques was counted and the virus
titer was calculated as plaque-forming unit (p.f.u.) per ml.
RNA interference
Mcl-1 siRNA (+): 59 GGACUUUUAGAUUUAGUGA dTdT
39, Bak siRNA (+): 59 AAGCGA AGTCTTTGCCTTCdTdC 39,
and non-targeting control EGFP siRNA (+): 59 GCAACGU-
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OD5 (solution form) from Sigma-Proligo (Sigma-Aldrich, Singa-
pore). GADD153 siRNA and its non-targeting control were both
purchased from Ambion (Applied Biosystems/Ambion, Austin,
Texas, USA). Transfection of siRNA into H1299 cells grown to
60% confluence was performed using DharmaFECT transfection
reagent (Dharmacon, Thermo Fisher Scientific Inc., USA)
according to the manufacturer’s instructions. At 72 hours post-
transfection, cells were infected with IBV at an M.O.I. of 1 at
various time points for protein and RNA analyses. Transfection of
siRNA into Huh7 cells grown to 90% confluence was performed
using Lipofectamine 2000 transfection reagent (Invitrogen Cor-
poration, Carlsbad, California, USA) according to the manufac-
turer’s instructions. A second transfection was performed 24 hours
after the first transfection. At 72 hours following the first
transfection, cells were infected with IBV at a M.O.I. of 1 at
various time points for protein and RNA analyses.
RNA isolation
Total RNA was isolated from IBV-infected cells using TRI
ReagentH (Molecular Research Center Inc., Ohio, USA) accord-
ing to the manufacturer’s instructions followed by addition of
chloroform at a volume 0.2 times that of TRI ReagentH. After
centrifugation at 12000 rpm at 4uC for 15 minutes, the RNA
fraction was transferred to a new tube and precipitated by 0.8
volume of isopropanol. After centrifugation, RNA pellets were
washed with 70% ethanol once and resuspended in RNase-free
H2O. The concentration of the total RNA extracted was
quantified using a NanoDrop
TM 1000 Spectrophotometer (Nano-
Drop Technologies, Inc., Thermo Fisher Scientific, USA).
RT-PCR
Reverse transcription (RT) was performed with Expand reverse
transcriptase (Roche) according to the manufacturer’s instructions.
The following chicken (gallus gallus) primers were used for PCR
analysis: Mcl-1 forward 59-AATCCCTGGAGCTCATCCTCC-
GG-39 and Mcl-1 reverse 59-AGATGAGCGTGACAACTCGG-
CC-39; Bak forward 59-GCGCAGGCCATCACGAGAGA-39 and
Bak reverse 59-CCGGCCCCAGTTAATGCCGC-39;G A P D Hf o r -
ward 59-GGGCTCATCTGAAGGGTGGTGCTA-39 and GAPDH
reverse 59-GTGGACGCTGGGATGATGTTCTGG-39;a n df o r
total viral RNA, IBV27101F (forward; 59-27101GAGTAACATAATG
GACCTGT27120-39) and IBV27510R (reverse; 59-27510TGCTGTA-
CCCTCGATCGTAC27491-39).
Plasmid DNA Transfection
The Mcl-1 plasmid is a full length Mcl-1 cloned into pXJ40-myc
plasmid, and the Bak plasmid is a full length Bak cloned into
pXJ40-myc plasmid. Transfection of both plasmids, as well as
pXJ40-myc empty vector as control, into H1299 and Huh7 cells
was performed using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions.
PCR probe labeling
PCR digoxigenin (DIG)-labeled DNA was used as probes for
Bak and Mcl-1 mRNAs. The DNA probe for the pXJ40-myc-Mcl-
1 plasmid corresponding to 251–715 nucleotides (nt) within the
open reading frame (ORF) was labeled by incorporation of DIG-
11-dUTP (Roche, Basel, Switzerland) during PCR. Likewise, the
DNA probe for the pXJ40-myc-Bak plasmid corresponding to
332–615 nt within the ORF was similarly labeled. As loading
control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-
specific probes were also synthesized. The oligonucleotides for
GAPDH-specific probe amplification are: (59R39) sense GTC-
AGTGGTGGACCTGACCT and anti-sense TGCTGCAGC-
CAAATTCGTTG.
Northern blotting
RNA was separated on 1.0% agarose gel and blotted to a
positively-charged nylon Hybond-N+
TM nylon membrane (Amer-
sham Biosciences, Piscataway, New Jersey, USA) overnight at
room temperature via capillary transfer and 206 SSC high-salt
transfer buffer (3 M NaCl, 300 mM Na3Citrate.H20, pH 7.0).
After transfer, the membrane was UV-crosslinked at 120 mJ/cm2
twice using the UV Stratalinker
TM 2400 (Stratagene, California,
USA), followed by pre-hybridization at 50uC for 1 hour. After pre-
hybridization, DIG-labeled DNA probe was denaturated at 100uC
for 5 minutes and immediately cooled on ice. Hybridization was
then performed with the denatured DIG-labeled DNA probe at
50uC for 16–20 hours. After hybridization, the membrane was
washed in 26 SSC, 0.1% SDS and 0.26 SSC, 0.1% SDS. The
membrane was then blocked in 16 Blocking Buffer (Roche
Biochemicals, Indianapolis, IN, USA) for 1 hour. The signal was
detected by probing with anti-Digoxigenin-AP (Roche), Fab
fragments from a sheep anti-digoxigenin antibody conjugated
with alkaline phosphatase at 1:10,000 dilution followed by
addition of the substrate CDP-Star chemiluminescent substrate
for alkaline phosphatase (Roche) according to the manufacturer’s
instructions.
Immunoblotting
Cells were infected with IBV for 0–36 hours, washed with PBS
and harvested using costarH cell scrapers (Corning, New York,
USA). After centrifugation at 12,000 rpm for 1 minute, the
supernatant was removed and the pellets lysed in SDS sample
buffer. The samples were boiled for 5 minutes prior to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
The gels were electrophoretically transferred to nitrocellulose
membranes and immunoblotted according to the standard
protocol with appropriate antibodies at proper dilutions. The
signals were detected using an ECL plus chemiluminescence
substrate kit (GE-Amersham, Buckinghamshire, UK).
TUNEL assay
The terminal deoxynucleotidyltransferase-mediated dUTP-bio-
tin nick end labeling (TUNEL) assay was performed using the
ApoAlertH DNA Fragmentation Assay Kit according to the
manufacturer’s instructions (Clontech, Takara Bio Company,
USA). Briefly, cells were fixed with paraformaldehyde and
permeabilized with Triton X-100 at room temperature. After
equilibration, specimens were overlaid with 100 ml TUNEL
reaction mixture and incubated in a humidified atmosphere for
60 minutes at 37uC in the dark. Samples with the incorporated
fluorescein were directly analyzed under a fluorescence micro-
scope using an excitation wavelength of 488 nm.
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) was used to validate Bak
and Mcl-1 gene expression changes in infected cells. Total RNA
(5 mg) was reversed transcribed to cDNA, and the resulting cDNA
was subjected to qPCR using Power SYBR Green PCR Master
Mix (Applied Biosystems). Primers for human Bak, Mcl-1 and
GAPDH genes are as follows: Bak forward 59-TGAGTACTT-
CACCAAGATTGCCA-39 and Bak reverse 59-AGTCAGGC-
CATGCTGGTAGAC-39; Mcl-1 forward 59-GTAATAACAC-
CAGTACGGACGG-39 and Mcl-1 reverse 59-TCCCGAAGGT
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TACATGTTC-39 and GAPDH reverse 59-GCCAGTGGACTC-
CACGAC-39. Amplification and data collection were performed
as manufacturer’s instruction (Applied Biosystems 7500 real-time
PCR system). The relative Bak and Mcl-1 expression levels were
calculated using GAPDH as an internal reference, and normalized
to Bak and Mcl-1 expression in mock-infected cells. All
experiments were performed in duplicates.
Results
Affymetrix array analysis of Bcl-2 family genes reveals up-
regulation of Bak and Mcl-1 and down-regulation of Bcl-2
variant a at the mRNA level in IBV-infected Vero cells
IBV-infection of human and animal cells induces apoptosis in
cultured cells at late stages of the infection cycle [16,30]. To study
the involvement of Bcl-2 family genes in the regulation of IBV-
induced apoptosis and viral pathogenesis, global gene expression
profiles were determined in Vero cells infected with IBV at an
M.O.I. of approximately 1 at 24 hours post-infection using
Affymetrix array analysis. As shown in Table 1, the expression
of 11 Bcl-2-related genes at the mRNA level was up-regulated and
2 down-regulated. Among them, a 5.28-fold induction of both Bak
and Mcl-1 and a 2.3-fold reduction of Bcl-2 variant a were
detected (Table 1). No detectable change was observed for other
Bcl-2-related genes in this screen.
IBV infection of Vero cells, chicken embryos and chicken
fibroblast cells up-regulates Bak and Mcl-1
Western blot analysis of IBV-infected cells, followed by
densitometry measurements, was then carried out to study the
expression of Bak, Mcl-1, Bax and Bcl-2 in IBV-infected Vero cells
at the protein level. In Vero cells infected with IBV at an M.O.I. of
1, significant up-regulation of both Bak and Mcl-1 was observed at
16 and 24 hours post-infection with an increase in IBV-N protein
expression as an indication of infection (Fig. 1A). In contrast,
constant levels of both Bax and Bcl-2 were detected throughout
the time-course experiments (Fig. 1A). Quantification of the
corresponding bands by densitometry measurement showed a
1.11–3.66-fold and a 1.10–2.82-fold induction of Bak and Mcl-1
from 8–24 hours post-infection, respectively (Fig. 1A). These
results demonstrate that both Bak and Mcl-1 are up-regulated at
the translational level in IBV-infected Vero cells.
In chicken fibroblast DF1 cells infected with IBV an M.O.I. of
1, moderate up-regulation of both Bak (1.39–2.09 fold) and Mcl-1
(1.14–1.30 fold) at the transcriptional level were also observed by
RT-PCR analysis at 8 and 16 hours post-infection (Fig. 1B). The
increase in expression levels of Bak (2.37 fold) and Mcl-1 (1.92
fold) in IBV-infected chicken embryos was observed as well
(Fig. 1C). This increase was also quantified by real-time PCR,
which, after normalization to mock-infected chicken embryos,
showed a 6.41- and 6.43-fold increase in Bak and Mcl-1 induction,
respectively, at 48 hours post-infection.
Active viral replication is required for up-regulation of
Mcl-1 and Bak at the transcriptional and translational
levels in IBV-infected Vero, H1299 and Huh7 cells
To further confirm the up-regulation of Bak and Mcl-1
expression during IBV infection and to study if this up-regulation
is cell type-specific, Vero, H1299 and Huh7 cells were infected
with IBV at an M.O.I. of 1 and harvested at 0, 8, 12, 16 and
24 hours post-infection, respectively. Northern blot analysis,
followed by densitometry measurements, of all three IBV-infected
mammalian cell lines showed an induction of both Bak and Mcl-1
transcripts at the mRNA level from 12 hours post-infection
(Fig. 2A). Quantification of the corresponding bands by densi-
tometry measurement showed a 1.04–4.66-fold and a 0.85–3.92-
fold induction of Bak and Mcl-1 In IBV-infected Vero cells from
8–24 hours post-infection, respectively. In IBV-infected H1299
cells, significant induction of Mcl-1 (1.67–9.51 fold) was detected
from 12–24 hours post-infection; however, relatively less efficient
induction of Bak (1.09–2.83 fold) was observed as the basal level of
Bak is much higher in this cell line. In IBV-infected Huh7 cells, a
1.28–2.06-fold and a 1.17–2.06-fold induction of Bak and Mcl-1
from 8–20 hours post-infection was observed. It was also noted
that the total mRNA of sufficient concentration could not be
extracted for IBV-infected Huh7 cells at 24 hours post-infection
due to the death and detachment of the infected cells (Fig. 2A). It
reflects a much faster rate of viral infection in this cell line.
To investigate if viral replication and synthesis of structural
proteins are required for the up-regulation of Bak and Mcl-1
transcripts, same amounts of UV-inactivated IBV were incubated
Table 1. Affymetrix array analysis of the expression of BCL2-related genes in IBV-infected Vero cells at 24 hours post-infection.
Gene Accession Number Induction fold (2
x) Description
BAK1 NM_001188.1 2.4 BCL2-antagonist/killer 1
MCL1 NM_021960.1 2.4 Myeloid cell leukemia sequence 1 (BCL2-related), transcript variant 1
BNIP1 U15172 0.9 BCL2/adenovirus E1B 19 kD-interacting protein 1
BCL2L1 NM_001191.1 0.8 BCL2-like 1, nuclear gene encoding mitochondrial protein, transcript variant 2
BECN1 AF139131.1 0.7 Beclin 1
BAG1 AF116273.1 0.7 BCL2-associated athanogene 1 protein variant
BAG-2 AF095192.1 0.7 BCL2-associated athanogene-family molecular chaperone regulator-2
BAG4 NM_004874.1 0.6 BCL2-associated athanogene 4
BAX NM_004324.1 0.4 BCL2-associated X protein
BAG3 NM_004281.1 0.3 BCL2-associated athanogene 3
BAX U19599.1 0.3 BCL2-associated X delta
BNIP3L AF060922.1 20.7 BCL2/adenovirus E1B 19 kDa interacting protein 3-like
BCL2 NM_000633.2 21.2 B-cell CLL/lymphoma 2 nuclear gene encoding mitochondrial protein transcript variant a
doi:10.1371/journal.pone.0030191.t001
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points as the cells infected with live IBV shown in Fig. 2A.
Northern blotting analysis showed that the up-regulation trend at
the transcriptional levels previously observed in live IBV-infected
cells was abolished for both Bak and Mcl-1 (Fig. 2A), confirming
that active viral replication is required for induction of the two
genes. The induction of Mcl-1 and Bak was also examined
quantitatively by real-time RT-PCR, which, after normalization to
UV-inactivated IBV-infected cells, showed significant induction in
Vero, H1299 and Huh7 cells infected with live IBV at 16 hours
post-infection. Specifically, Mcl-1 induction showed a 4.96-, 5.97-
and 9.75-fold increase, and Bak induction saw a 7.00-, 10.66- and
4.04-fold increase in IBV-infected Vero, H1299 and Huh7 cells,
respectively.
The induction kinetics of Mcl-1 and Bak at the protein level in
IBV-infected Vero, H1299 and Huh7 cells were then characterized.
Cells were infected with IBV at an M.O.I. of 1, and harvested at 0,
8, 12, 16 and 20 hours post-infection, respectively. Immunoblotting
was carried out, followed by densitometry measurements. Virus
infection efficiency was monitored by Western blot analysis of the
same cell lysates with anti-IBV S antibodies, showing efficient
detection of the S protein expression in these cells from 12 hours
post-infection (Fig. 2B). Moderate up-regulation of Mcl-1L protein
(40 kDa) was observed in all three cell lines infected with IBV
(Fig. 2B). Densitometry measurements of the corresponding bands
showed a 1.26–2.59 fold induction of Mcl-1 In IBV-infected Vero
cells from 8–20 hours post-infection. Up-regulation of Mcl-1
protein expression was also observed in IBV-infected H1299 (1.1–
1.97 fold) and Huh7 (2.35–2.98 fold) cells. However, down-
regulation of the protein expression was consistently observed in
IBV-infected H1299 cells at 20 hours post-infection (Fig. 2B). This
could be due to the fact that Mcl-1 has a short half-life and is
Figure 1. Analysis of the expression of BCL2-related proteins in IBV-infected Vero cells, chicken fibroblast DF1 cells and chicken
embryos. (A) Vero cells were infected with IBV, harvested at 0, 8, 16 and 24 hours post-infection, and lysates prepared. Western blot analysis was
performed with the indicated specific antibodies, and probed with anti-actin as a loading control. (B) Chicken fibroblast DF1 cells were either infected
with IBV, harvested at 8 and 16 hours post-infection and RNA extracted. RT-PCR analysis was carried out using specific primers for the indicated
genes, with GAPDH as a loading control. (C) 10-day-old chicken embryos were inoculated with either mock virus (M) or IBV (1000 plaque-forming
units per egg) in a 37uC incubator for 48 hours. Total RNA was extracted from homogenized tissues and used for RT-PCR using specific primers as
above (B).
doi:10.1371/journal.pone.0030191.g001
Regulation of Mcl-1 and Bak by Coronavirus IBV
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30191subjected to constitutive polyubiquitination and subsequent protea-
some degradation [31], which might account for the decline in its
expression in some, but not all, virus-infected human cells [32].
In normal, healthy cells, Bak is localized to the mitochondrial
outer membrane as an inactive monomer. After appropriate
apoptotic stimuli, Bak undergoes an activating conformational
change that results in the formation of higher-order multimers
[33]. Analysis of Bak monomer (24 kDa) expression showed an up-
regulation trend in IBV-infected Vero, H1299 and Huh7 cells
(Fig. 2B). Densitometry measurements of the corresponding bands
showed 1.02–1.79, 1.37–1.48 and 1.84–2.63 fold induction of Bak
in IBV-infected Vero, H1299 and Huh7 cells from 8–20 hours
post-infection, respectively.
Knockdown of Mcl-1 and Bak by RNA interference
regulates IBV-induced apoptosis
The effects of Mcl-1 and Bak knockdown on IBV-induced
apoptosis was first assessed by using the TUNEL assay. H1299
cells were transfected with siRNA duplexes targeting Mcl-1(siMcl-
1), Bak (siBak) or EGFP (siEGFP), respectively, and either mock-
infected or infected with IBV at an M.O.I. of 1 at 36 hours post-
transfection. At 20 and 24 hours post-infection, cells were fixed
and permeabilized before overlaying with the TUNEL reaction
mixture, which labels apoptotic cells such that samples with the
incorporated fluorescein can be visualized under a fluorescence
microscope (Fig. 3A). Significantly more apoptotic cells were
observed in Mcl-1 knockdown cells infected with IBV compared to
the control cells transfected with siEGFP, or with Bak-knockdown
cells at both 20 and 24 hours post-infection, whereas little or no
apoptotic cells were observed in mock-infected cells (Fig. 3A).
These results demonstrate that knockdown of Mcl-1 appears to
speed up the onset of IBV-induced apoptosis, whereas silencing of
Bak causes a slight delay.
The specific regulatory roles of Bak and Mcl-1 in IBV-induced
apoptosis were further studied by examining the cleavage kinetics
of PARP (116 kDa). This zinc-dependent eukaryotic DNA-
binding protein specifically recognizes DNA strand breaks
produced by genotoxic agents, and is normally involved in DNA
repair, DNA stability and other cellular events. It is one of the
substrates cleaved by members of the caspase family during early
apoptosis, and detection of the caspase cleavage fragment (85 kDa)
of PARP has long been considered to be a hallmark of apoptosis
[34]. Using siEGFP as a negative control, Western blot analysis,
followed by densitometry measurements, of H1299 and Huh7 cells
Figure 2. Analysis of Bak and Mcl-1 expression at the mRNA and protein levels in IBV-infected mammalian cells. (A) Northern blot
analysis of Bak and Mcl-1 expression at the mRNA level in IBV-infected mammalian cells. Vero, H1299 and Huh7 cells infected with (A) IBV or (B) UV-
IBV were harvested at 0, 8, 12, 16 and 24 hours post-infection, respectively, and total RNA was extracted. Northern blot analysis was carried out with
specific probes for Bak and Mcl-1. The same membrane was also probed with a GAPDH probe as a loading control. (B). Western blot analysis of Bak
and Mcl-1 expression at the protein level in mammalian cells. Vero, H1299 and Huh7 cells infected with IBV were harvested at 0, 8, 12, 16, 24 and
36 hours post-infection, respectively, and cell lysates prepared. Western blot analysis was performed using specific antibodies as indicated, with anti-
actin as a loading control. M, mock infection.
doi:10.1371/journal.pone.0030191.g002
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specifically decreased by siMcl-1 and siBak, respectively, in both
H1299 and Huh7 cells (Fig. 3B). Interestingly, the detection of the
85 kDa PARP cleavage fragment in both cell lines appeared to be
inversely correlated with Mcl-1 expression levels. As shown in
Fig. 4B, a significantly more amount of the cleavage product was
detected in IBV-infected, Mcl-1 knockdown H1299 (29%) and
Huh7 (30%) cells at 20 hours post-infection, compared to the same
infected cell lines treated with either siBak (0% in both cell lines) or
siEGFP (23% in H1299 and 0% in Hun7). The same trend was
also observed at 24 hours post-infection, although more cleavage
product was detected in siEGFP-treated Huh7 cells (Fig. 3B). As
no significant amount of Mcl-1 was observed in siEGFP-
transfected H1299 and Huh7 cells at 24 hours post-infection
(Fig. 3B), it may suggest rapid proteasome degradation of the
protein as observed previously.
In contrast, PARP cleavage was not observed in IBV-infected,
siBak-transfected H1299 and Huh7 cells at 20 hours post-
infection, and in H1299 cells at 24 hours post-infection (Fig. 3B).
The appearance of the PARP cleavage fragment in Bak-silenced
H u h 7c e l l sa t2 4h o u r sp o s t - i n f e c t i o n ,a l b e i ta tl o w e rl e v e l sa s
those in similarly infected Mcl-1 and EGFP knockdown Huh7
cells, could be attributed to a slight decrease in Mcl-1 expression
in the Bak knockdown cells (Fig. 3B). Taken together, these
results confirm that Mcl-1 may play a part in the regulation of
IBV-induced apoptosis, and a decrease in the Mcl-1 expression
in cells could enhance IBV-induced apoptosis at earlier stages of
infection.
Over-expression of Mcl-1 and Bak regulates IBV-induced
apoptosis differentially
The differential regulatory effects of Mcl-1 and Bak on IBV-
induced apoptosis were further studied by over-expression of Mcl-
1 and Bak in mammalian cells. For this purpose, Myc-tagged Mcl-
1 and similarly-tagged Bak were constructed and transfected into
H1299 and Huh7 separately, using an empty vector as a negative
transfection control. The cells were then infected with IBV at an
M.O.I. of 1. At 24 hours post-infection, we observed a significant
increase in PARP cleavage in both H1299 (3.25 fold) and Huh7
(2.73 fold) cells transfected with Myc-Bak (Fig. 4). In contrast, the
full-length PARP was not significantly cleaved in both IBV-
infected H1299 and Huh7 transfected with Myc-Mcl-1 (Fig. 4). It
was noted that a significant increase (2.88 fold) of PARP cleavage
was observed in IBV-infected H1299 cells transfected with
siEGFP, reflecting a high level of viral replication in these cells
as described in a later section. These results further confirm the
respective roles Mcl-1 and Bak may play in regulating the onset
and rate of IBV-induced apoptosis.
IBV-mediated Mcl-1 induction is reduced by inhibition of
both ERK and PI3K pathways, and by silencing of
GADD153
We then checked the upstream signaling pathways that may
play a role in regulating the induction of Mcl-1 in IBV-infected
cells. Recent reports suggested that ER stress, in particular the
downstream activation of MEK/ERK and PI3K/Akt signaling
Figure 3. The effects of knockdown of the expression of Bak and Mcl-1 in mammalian cells on IBV-induced apoptosis and PARP
cleavage. (A) TUNEL assay of the effects of down-regulation of Bak and Mcl-1 by RNA interference in mammalian cells on IBV-induced apoptosis.
H1299 cells were transfected with siRNA duplexes targeting Mcl-1, Bak or EGFP, respectively. At 72 hours post-transfection, cells were either mock-
infected, or infected with IBV, then fixed and permeabilized at 20 and 24 hours post-infection. Cells were then stained with the TUNEL reaction
mixture and images were taken with a fluorescence microscope at an excitation wavelength of 488 nm. (B) Western blot analysis of the effects of
down-regulation of Bak and Mcl-1 by RNA interference in mammalian cells on IBV-induced apoptosis and PARP cleavage. H1299 (upper panel) and
Huh7 cells (lower panel) were transfected with siRNA duplexes targeting Mcl-1, Bak or EGFP. At 72 hours post-transfection, cells were infected with
IBV and harvested at 20 and 24 hours post-infection. M, mock infection. Western blot analysis was performed using the indicated specific antibodies,
with anti-tubulin as a loading control.
doi:10.1371/journal.pone.0030191.g003
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Bcl-2 family of proteins [35]. The involvement of MAP/ERK and
PI3K kinase pathways in regulation of IBV-induced Mcl-1 was
first studied by infection of Vero and H1299 cells with IBV at an
M.O.I. of 2 in the presence or absence of either 20 mM of MAP/
ERK kinase MEK-1 inhibitor U0126 or 40 mM of PI3K inhibitor
LY294002. Mcl-1 induction was quantitatively defined by real-
time RT-PCR at 16 hours post-infection, showing that both
U0126 and LY294002 significantly reduced the Mcl-1 induction
in both cell lines, compared to the control cells treated with
DMSO alone (Fig. 5A). As U0126 was also able to inhibit IBV
infection at the same concentration (data not shown), the
inhibitory effect observed was probably due to the reduced viral
replication.
The inhibitory effects of U0126 on virus infection warranted
a closer look of the upstream signals that may regulate the
MAP/ERK pathway. GADD153, also known as C/EBP
homologous protein (CHOP), is a pro-apoptotic transcription
factor and well-known component of several ER stress-mediated
pathways, including the MAP/ERK pathway [35,36,37].
Induction of GADD153 has been found to regulate different
members of the Bcl-2 family [3,38]. Downstream of the ER
stress–mediated up-regulation of GADD153 expression is a
correlated suppression of Akt signaling [39]. The activation of
the latter is, in turn, known to up-regulate Mcl-1 through its Akt
kinase [40]. Induction of GADD153 in IBV-infected cells was
observed (data not shown). To elucidate the regulatory roles, if
any, for GADD153 in the induction of Mcl-1, H1299 cells
transfected with either siRNA duplexes targeting GADD153
(siGADD153) or a non-targeting control (siControl) were
infected with IBV at an M.O.I of 1 for 16–20 hours and
harvested for Western blot analysis, followed by densitometry
measurements. We observed a corresponding reduction in the
expression of Mcl-1 (40–73% down-regulation) with a decreased
GADD153 expression (21–27% knockdown efficiencies) in IBV-
infected cells, alongside a 66–98% reduction in viral replication
efficiency, compared to that in infected control cells (Fig. 5B).
These results suggest the possible involvement of many signaling
pathways in the modulation of Mcl-1 induction, including
MAP/ERK and ER stress, leading to the regulation of virus-
induced apoptosis.
Knockdown of Mcl-1 and Bak by RNA interference
regulates the replication and release of IBV at late stages
of the infection cycle
The effects of Mcl-1 and Bak knockdown on IBV replication
and release were first examined by Western blot analysis and
densitometry measurements of IBV S and N proteins in total cell
lysates and in culture medium. The reason for choosing Western
blotting analysis of viral proteins in total cell lysates and culture
medium instead of viral titration was that the viability of IBV was
heavily influenced by the transfection reagents as well as DMSO
used in some experiments. Measurements of viral protein synthesis
and release would more accurately reflect the effects of apoptosis
and its regulation on IBV replication. While the release of viral
protein/particles were enhanced with decreased expression levels
of Mcl-1, compared to that in Bak knockdown and control cells,
IBV S and N protein expression levels in total cell lysates were only
slightly higher in Mcl-1 knockdown cells at 20 hours post-
infection, and largely comparable with siEGFP-transfected cells
at 24 hours post-infection (Fig. 6A). Bak knockdown H1299 cells,
on the other hand, showed a decrease in viral replication
efficiency, although slightly less so in similarly knocked down
Huh7 cells (Fig. 6A).
The effects of Bak and Mcl-1 knockdown by RNA interference
on IBV RNA replication were checked. Bak and Mcl-1
knockdown and control H1299 cells infected with IBV at an
M.O.I. of 1, harvested at various time points from 0 to 20 hours
post-infection, and total RNA was extracted for Northern blot
analysis, followed by densitometry measurements. We observed
that knockdown of either Bak or Mcl-1 renders minimal, if any,
effects on the replication and transcription of IBV RNA. As shown
in Fig. 6B, no consistent trends of increase/decrease of viral RNA
were observed in Bak and Mcl-1 knockdown cells infected with
IBV compared to the siEGFP control cells. The observed
variations among different samples may be caused by experimen-
tal factors. These results suggest that, as would be expected,
manipulation of the Bak and Mcl-1 expression renders little effort
on IBV replication at these early stages of the infection cycle. It
may also reflect the sensitivity of the assay used.
The effects of over-expression of Mcl-1 and Bak in mammalian
cells shown in Fig. 4 on IBV replication and release were
analyzed by Western blot analysis of IBV S and N proteins in
total cell lysates and culture media. While the expression of IBV-
S protein in total cell lysates showed little or no increase in IBV
infected H1299 (96%) and Huh 7 (90) cells over-expressing Bak
Figure 4. The effects of Mcl-1 and Bak over-expression in
mammalian cells on IBV-induced PARP cleavage. H1299 (upper
panel) and Huh7 cells (lower panel) were transfected with pxj40-myc-
Mcl-1, pxj40-myc-Bak or pxj40-myc empty vector and either mock-
infected (M) or infected with IBV at 16 hours post transfection. Cells
were harvested 24 hours post infection and western blot analysis was
performed using the indicated specific antibodies, with anti-tubulin as a
loading control.
doi:10.1371/journal.pone.0030191.g004
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release of virus proteins/particles was observed, as is evident in
the increase in IBV-S and -N protein expression levels in the
culture medium of infected H1299 (2.1-fold for S protein and 2.3-
fold for N protein) and Huh7 (1.43-fold for S protein and 1.54-
fold for N protein cells) transfected with Myc-Bak (Fig. 6C). The
contrary was observed in the culture medium of infected cells
over-expressing Mcl-1 (Fig. 6C). It was also noted that
overexpression of Myc-Mcl-1 significantly inhibited the replica-
tion of IBV in H1299 cells (Fig. 6C). Taken together, these results
further confirm the respective roles Mcl-1 and Bak play in
regulating the rate of both IBV-induced apoptosis and viral
progeny release.
Discussion
Viral regulation of programmed cell death is a sophisticated
process [1]. It is also a complex aspect of viral pathogenesis. In the
past few decades, numerous viruses have been shown to
manipulate various apoptotic pathways to their own advantage
[41]. Viruses may inhibit apoptosis during the initial stages of
infection so as to garner enough time to multiply and disperse
rapidly from the plasma membrane to infect other cells [42]. Yet,
viruses may just as easily infect a cell, elicit apoptosis, and spread
to neighbouring cells through phagocytosis of the resulting
apoptotic bodies while cleverly minimizing an immune response
at the same time [43]. It has also been previously reported that
SARS-CoV induces apoptosis as well, both in vitro and in vivo,
which might account for the destruction of lung epithelial cells in
infected patients [44].
In this study, global gene expression profiles have been first
determined in IBV-infected Vero cells at 24 hours post-infection
by Affymetrix array, revealing an up-regulation at the transcrip-
tional level of both pro-apoptotic Bak and pro-survival Mcl-1.
These results were further confirmed in IBV-infected chicken
embryos and chicken fibroblast DF1 cells, as well as mammalian
cells such as H1299, Vero and Huh7 cells. As apoptosis is
influenced, both positively and negatively, by a variety of genes
including various members of the Bcl2 gene family [45], up-
regulation of Bak and Mcl-1 may play essential roles in
maintaining the intricate balance between life and death of
infected cells to ensure a successful infection cycle. Our data show
that IBV viral protein release was increased in cells with
knockdown of the anti-apoptotic Mcl-1 protein, and in cells
over-expressing the pro-apoptotic Bak protein. Likewise, PARP
cleavage occurs earlier in cells depleted of Mcl-1, and in cells with
elevated levels of Bak. This points to the importance of these two
members of the Bcl2 family in regulating IBV-induced apoptosis,
especially at an early stage of infection. Mcl-1 and Bak also
appear to be involved in regulating viral replication efficiency at
late stages of infection, as a decrease in Mcl-1 expression levels
and an increase in that of Bak promote virus progeny release. A
tricky balance between the two may therefore be a key requisite
in first maintaining the integrity of the host cell environment
during infection before the conclusion of a triumphant infection
cycle.
A moderate enhancement effect on viral protein synthesis and
viral particle release was observed in Mcl-1 knockdown cells
infected with IBV in the late stages of infection. As Mcl-1 is
unlikely involved in direct viral RNA replication and protein
Figure 5. Regulation of Mcl-1 expression by MEK-1, PI3K and GADD153. (A) Induction of Mcl-1 in IBV-infected cells in the presence or
absence of either 20 mM of MEK-1 inhibitor U0126 or 40 mM of PI3K inhibitor LY294002. Vero, and H1299 cells were incubated with normal medium
(DMSO-), LY294002 in DMSO, U0129 in DMSO and DMSO only (DMSO+) for 1 hour, and then infected with IBV at a multiplicity of infection of
approximately 2 in the presence or absence of the inhibitors. Cells were harvested at 16 hours post-infection, and total RNA extracted. The relative
amounts of Mcl-1 transcripts were determined by quantitative RT-PCR and normalized against GAPDH. The relative fold of Mcl-1 induction in IBV-
infected cells was determined by comparing with mock-infected cells. (B) Induction of Mcl-1 in IBV-infected cells by the pro-apoptotic transcription
factor GADD153. H1299 cells were transfected with either siGADD153 or a non-targeting control for 72 hours and subsequently infected with IBV.
Cells were harvested at 16, 18 and 20 hours post infection for western blot analysis using specific antibodies against the indicated proteins, with anti-
actin as a loading control. M, mock infection.
doi:10.1371/journal.pone.0030191.g005
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knockdown cells than that in the control cells at these time points
would be due to the fact that more infectious viral particles were
released from the primary infection. Subsequently, these viruses
could infect more neighboring cells during secondary and tertiary
infections, resulting in the detection of more viral proteins. In fact,
minor, if any, differences in viral RNA replication and protein
synthesis were observed at the earlier stages of infection, lending
support to this conclusion. On the other hand, the minimal to
moderate regulatory effect observed in Mcl-1 knockdown cells
may not truthfully reflect the actual impact of Mcl-1 up-regulation
on viral replication and pathogenesis in the infected animals. This
issue can be addressed only in Mcl-1 knockout mouse or other
suitable animal models. Nevertheless, it appears that up-regulation
of Mcl-1 in IBV-infected cells, as characterized here, may
represent an effective host anti-coronavirus response that regulates
viral infectivity and productivity.
The expression profiles of Mcl-1 and Bak at the protein level
demonstrated in this study appear to be differentially regulated by
the efficiency of IBV replication in different host cells. In IBV-
infected H1299 and Huh7 cells, Mcl-1 was shown to be gradually
decreased at late time points. As explained earlier, Mcl-1 has a
short half-life as it undergoes polyubiquitination and subsequent
proteasome degradation. The down-regulation observed during
late stages of virus infection may be due to the rapid degradation
of the protein. It also suggests that, unlike in Chlamydia
trachomatis-infected cells [46], IBV infection does not stabilize
Mcl-1 protein, particularly in human cells. Another reason is that
more efficient viral replication and infection are usually observed
in these two cell lines, especially in Huh7 cells, compared to that in
Vero cells, leading to the destruction of the monolayers and
degradation of cellular RNAs.
Attempts to identify the viral component(s) that is responsible
for up-regulation of Bak and Mcl-1 were made but without
Figure 6. The effects of manipulation of the expression of Bak and Mcl-1 on the replication and transcription of IBV RNA and the
synthesis of IBV proteins in mammalian cells. (A) The effects of down-regulation of Bak and Mcl-1 by RNA interference on the synthesis of IBV
proteins in mammalian cells. H1299 cells were transfected with siRNA duplexes targeting Mcl-1, Bak and EGFP, and infected with IBV at 72 hours post-
transfection. The culture medium and cells were harvested separately for Western blot analysis, using specific antibodies for IBV-S and IBV-N and anti-
tubulin as a loading control. M, mock infection. (B) The effects of down-regulation of Bak and Mcl-1 by RNA interference on the replication and
transcription of IBV RNA in mammalian cells. Cells were harvested for Northern blot analysis, using specific probes for Bak, Mcl-1 and the 39-UTR of
IBV, with a GAPDH probe as loading control. (C) The effects of over-expression of Bak and Mcl-1 on the synthesis of IBV proteins in mammalian cells.
H1299 (upper panel) and Huh7 cells (lower panel) were transfected with pxj40-myc-Mcl-1, pxj40-myc-Bak or pxj40-myc empty vector and either
mock-infected (M) or infected with IBV at 16 hours post transfection. The culture medium and cells were harvested separately 24 hours post
infection, and western blot analysis was performed using the indicated specific antibodies, with anti-tubulin as a loading control.
doi:10.1371/journal.pone.0030191.g006
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regulation of these two genes at the transcriptional level. As the
UV-inactivated virus fails to induce the expression of the two
proteins, it suggests that IBV structural proteins, at least at low
concentration, do not play a direct role. In fact, transfection of
individual IBV proteins into cells did not induce the expression of
these two proteins (unpublished observations).
The complex of Mcl-1 and Bak in an otherwise healthy cell can
be disrupted by various factors, including mitochondrial p53 [2]
and other members of the Bcl-2 family [47]. Mcl-1 activation can
also be triggered by many signaling events, including MAPK
pathways, PI3K/AKT pathway, growth factors and cell stress
[3,11,35,46]. From our data, it appears that the induction of Mcl-1
protein in IBV-infected cells is indeed affected by the activation of
MEK and/or PI3K pathways, as well as by upstream activators
such as the transcriptional regulator of ER-stress mediated
apoptosis, GADD153. In a previous study, we showed IBV
infection induced the expression of GADD34 [48], indicating
activation of the double-stranded RNA- activated protein kinase-
like ER kinase (PERK) branch of the unfolded protein response
(UPR) in IBV-infected cells. The observed up-regulation of
GADD153 in IBV-infected cells in this study would lend further
support to this conclusion. ER stress also activates the inositol-
requiring enzyme 1 (IRE1) branch of the UPR, which, other than
its role in the cleavage and degradation of misfolded proteins,
serves to transcriptionally up-regulate Mcl-1 through its down-
stream activation of the PI3k/Akt pathway [49,50]. The induction
of Mcl-1, likely the consequence of a combination of viral RNA
replication, protein synthesis and cellular signal cascades triggered
by all these events, would then attenuate Bak activation and
subsequent apoptosis.
In addition to understanding the virus-host cell interaction and
viral pathogenesis, this study would have a potential practical
application. With the ability of viruses to behave as oncolytic,
apoptosis-inducing agents [43] and the rapid advances in
molecular biology, apoptotic viral genes can be harnessed as
vectors and targeted to tumor cells as a potential anti-cancer
therapeutic benefit [51]. Degenerative diseases such as Alzhei-
mer’s disease and Huntingdon’s disease may also be similarly
treated with anti-apoptotic viral genes [1]. Investigating the
relationship between Bcl2 family proteins and IBV-induced
apoptosis may lead to further refinement of the virotherapy
concept [52] to develop safer, virally-derived gene therapies that
will target cancer cells with more discrimination.
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